Positionspapier zur medikamentenassoziierten Osteonekrose des Kiefers (MRONJ)

This publication has 27 references indexed in Scilit:

• Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
  Journal of Bone and Mineral Research, 2014
• Epidemiology, Clinical Manifestations, Risk Reduction and Treatment Strategies of Jaw Osteonecrosis in Cancer Patients Exposed to Antiresorptive Agents
  Future Oncology, 2014
• Metastatic Cancer Identified in Osteonecrosis Specimens of the Jaws in Patients Receiving Intravenous Bisphosphonate Medications
  Journal of Oral and Maxillofacial Surgery, 2013
• Economic burden of osteoporotic fractures in Austria
  Health Economics Review, 2012
• Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis
  The Journal of the American Dental Association, 2011
• Risk Factors for Osteonecrosis of the Jaws
  Journal of Dental Research, 2011
• Teriparatide Therapy for Alendronate-Associated Osteonecrosis of the Jaw
  New England Journal of Medicine, 2010
• Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients
  Annals of the New York Academy of Sciences, 2010
• Combination of Bisphosphonates and Antiangiogenic Factors Induces Osteonecrosis of the Jaw More Frequently than Bisphosphonates Alone
  Oncology, 2009
• Osteonecrosis of the jaw—a potential adverse effect of bisphosphonate treatment
  Nature Clinical Practice Endocrinology & Metabolism, 2006